Skip to main content
OpenTrials

Clinical trial condition

Waldenström Macroglobulinemia

Explore clinical trials studying Waldenström Macroglobulinemia. Study availability and eligibility vary by location and protocol.

70 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Waldenström Macroglobulinemia trial results

Recruiting

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

NCT05006716

Conditions
B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +37 more
Locations
  • University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
  • Mayo Clinic Phoenix Phoenix, Arizona, United States
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
View all 127 locations
View Trial Details
Recruiting

Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader

NCT05294731

Conditions
B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +36 more
Locations
  • The First Affiliated Hospital of Bengbu Medical University Bengbu, Anhui, China
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Beijing Chao Yang Hospital,Capital Medical University Beijing, Beijing Municipality, China
View all 29 locations
View Trial Details
Completed

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

NCT02362035

Conditions
Blood Protein Disorders, Burkitt Lymphoma, CLL, +47 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Completed

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

NCT02213913

Conditions
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, +104 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Chicago Chicago, Illinois, United States
  • Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States
  • NorthShore University HealthSystem Evanston, Illinois, United States
View Trial Details

Related conditions